2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
DN¼Ö·ç¼ÇÁî ±Ý¼Ó 3DÇÁ¸°ÅÍ, ÇØ±º Çʼöǰ µÆ´Ù (2024-07-21)
Philip Morris International Releases Integrated Report 2022 (2023-04-06)
'´õ ´º ¾Æ¹Ý¶¼ N TCR¡¯ 2024 TCR ¿ùµåÅõ¾î 4¶ó¿îµå ¿ì½Â (2024-07-23)
½º¸¶Æ®Æù Àá½Ã ¸ØÃã, û¼Ò³â ¡®¶Ñ¹÷¶Ñ¹÷ µðÁöÅÐ µðÅ彺¡¯ Ä·ÆäÀÎ (2024-07-23)
ÀÓ¿µ¿õ, ¸¶ÀÌ¿øÇÈ Æ®·ÎÆ® ºÎ¹® 100ÁÖ ¿¬¼Ó 1À§ ´Þ¼º (2024-05-28)
Dalberg Awarded 5-Year Contract to Strengthen United States ... (2024-03-31)
ÀÚ¿øºÀ»çȰµ¿ ±âº»¹ý, 20³â°£ ÇÑ ¹øµµ ¹Ù²ï Àû ¾ø¾î (2024-03-02)
¸Ó½½¸¶´Ï¾Æ Á¤ÀÎÇý¡¤ÀÌ¿¬¡¦ ȯ»ó ¸ö¸Å ºñ°áÀº ´Ü¹éÁú Çコº¸ÃæÁ¦ (2015-06-06)
AGCO Continues Technology Transformation to Become an Indust... (2023-11-13)
Tecnotree Selected to Provide Multi-Tenant MVNE Platform and... (2024-11-24)
19´ë ±¹È¸ ±¹°¨ ±â¾÷ÀÎ ÁõÀÎ ¼ö, 16´ë ±¹È¸º¸´Ù µÎ ¹è (2015-09-22)
Medisca Expands Strategic Partnerships to Drive Patient Acce... (2023-07-28)
¿ìüÅë¿¡°Ô º¸³»´Â ½°Ç¥¡¦ º¯¿ì¼®, ¡®µð¾ÆÀÌÄÜ¡¯ÀÇ º¯½Å (2024-11-26)
»ï¼ºÀüÀÚ, Å©·¡ÇÁÅæ°ú ¡®´ÙÅ©¾Ø´ÙÄ¿ ¸ð¹ÙÀÏ¡¯ °ÔÀÓ Çù¾÷ (2024-08-04)
100°³ÀÇ »ç·Ê·Î ¾Ë¾Æº¸´Â ½Äǰ Ç¥½Ã±¤°í (2023-09-28)
±ºÀΰøÁ¦È¸¿ø »ýȰ¾ÈÁ¤ ¹× º¹ÁöÁõÁø ¡®ÅðÁ÷±Þ¿©´ë¿©¡¯ (2023-12-24)
¼¼°è ¾ØÆ²·¯ ÆÝµå ¸Å´ÏÀúµé ¼­¿ï·Î Áý°á (2024-06-11)
¹Ð°É·¹ÀÇ Å»¼ö¿Í °ÉÀÌ ±â´É, ÇϳªÀÇ ¾çµ¿ÀÌ·Î (2015-11-03)
GS25, Çѱ¹µµ·Î°ø»ç¿Í ¡®ÈÞ°Ô¼Ò Àαâ À½½Ä¡¯ »óǰȭ MOU (2024-07-10)
First Doses of BRUKINSA provided to Patients with Chronic Ly... (2024-03-20)
¡®¸®¾ó ¿¬¾Ö½ÇÇè½Ç µ¶»ç°ú¡¯ ½Ãû·üXÈ­Á¦¼º ´Ù Àâ¾Ò´Ù (2024-06-13)
»ï¼º¹°»ê ·¡¹Ì¾È, VR ±â¼ú·Î ÀÔÁÖ °í°´ AS Æí¸®ÇØÁø´Ù (2024-05-17)
Pharmanovia Signs Novel Biologic In-Licensing Agreement With... (2024-11-30)
Çö´ëÂ÷ Á¤¸ù±¸ Àç´Ü, ÀÓÆÑÆ® ½ºÅ¸Æ®¾÷ Ä·ÇÁ °³ÃÖ (2024-05-19)
¹Ý·Áµ¿¹°ÀÇ °üÀý¡¤½½°³°ñ ¿µ¾çÁ¦ ¡®ÆêÁöŰ¹Ì º»ÅõÆê¡¯ Ãâ½Ã (2024-06-17)
       [ÀÌÀü][1]....[595][596][597][598][599][600][601][602][603]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..